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Introduction
The sympathetic nervous system (SNS) is a homeostatic regulator of cardiovascular, metabolic and immune functions under basal conditions, in the face of acute or chronic changes in physiological state, and in response to stress. In immune organs, the SNS regulates immune function via tonic release of its major transmitter, norepinephrine (NE) (Bellinger et al., 2008a,b) . NE binds with adrenergic receptors (ARs; predominantly β 2 ) expressed on immunocytes to increase cAMP production (Halper et al., 1984; Staehelin et al., 1985) . The SNS modulates a wide variety of immune measures, and affects the development and progression of immune-mediated diseases (reviewed in Bellinger et al., 2008b) .
With aging, basal sympathetic nerve activity (SNA) progressively rises (Docherty, 2002) , and SNS responses after activation are exaggerated (McCarty et al., 1997) . The functional significance of hyperactive SNA in immune organs remains unclear and understudied. Presumably, it occurs at the expense of fine control, at the risk of over-stimulating target tissues, and places additional metabolic strain (allostatic load) on all target organs (Goldstein and McEwen, 2002) . Higher SNA can alter immune cell trafficking (Redwine et al., 2003) and host defense (Bellinger et al., 2008b) , and may be a risk factor for developing immune-mediated diseases that increase in frequency with advancing age (Cohen et al., 2001; Bellinger et al., 2008b) . Furthermore, the extent to which aging changes in SNS functioning mediate, or contribute to, the aging changes in immune function, i.e. a causal relationship between these two phenomena, remains unknown. This lack of information is due, in part, to a lack of clear understanding of target-specific changes in SNS function across age, and the lack of model systems that can reverse the age-induced SNS changes in immune target organs, which is necessary to test this hypothesis in vivo.
In aging male Fischer 344 (F344) rats, sympathetic innervation progressively declines in secondary lymphoid organs (Bellinger et al., 1992 (Bellinger et al., , 2001 (Bellinger et al., , 2008a . Nerve loss resembles a peripheral neuropathy in that nerves recede distally to proximally from their entry sites into the spleen, the hilar region. Nerve loss precedes a significant loss in splenic NE levels, suggesting enhanced NE metabolism as an early compensatory event. This is consistent with a slight, but significant rise in splenic NE concentrations in 10 M rats and increased NE turnover between 10 and 15 months. In 24 month-old (M) rats, Journal of Neuroimmunology 247 (2012) 38-51 
